Approval · Notice of Compliance 2502 · 2001
PENTASPAN: Notice of Compliance 2502
Issued November 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2502
- Date
- November 22, 2001
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Plasma volume expander
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASPAN | 00887110 | Cancelled Post Market |
Medicinal ingredients
- PENTASTARCH 10 G per 100ML
- SODIUM CHLORIDE 900 MG per 100ML